| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |